Live Breaking News & Updates on Martinw Schoen

Stay updated with breaking news from Martinw schoen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Prostate-specific antigen failure risk factors in nonmetastatic unfavorable-risk prostate cancer

Prostate-specific antigen failure risk factors in nonmetastatic unfavorable-risk prostate cancer
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Dana Farber Cancer Institute , United States , Martinw Schoen , Mutlay Sayan , Sciencex Network , Cumulative Incidence Curves , Short Term Prostate Specific Antigen Recurrence , Patients With Prostate Cancer , Recurrence After Radiation , Early Prostate Cancer , Risk Stratification From Prospective Trials ,

Hospitalization Risk Higher With Abiraterone Than With Enzalutamide

Patients with metastatic prostate cancer treated with abiraterone have a higher rate of hospitalization than those treated with enzalutamide. ....

United States , Saint Louis University , Martinw Schoen , Saint Louis University School Of Medicine , Clinical Genitourinary , Forest Riekhof , Saint Louis University School ,

Hospitalization Risk Higher With Abiraterone vs Enzalutamide

Abiraterone vs enzalutamide treatment for metastatic prostate cancer is associated with higher rates of hospitalization, a study found. ....

United States , Saint Louis University , Martinw Schoen , Saint Louis University School Of Medicine , Forest Riekhof , Saint Louis University School , Saint Louis , Clinical Genitourinary ,

Hospitalization Risk Higher With Abiraterone vs Enzalutamide

Abiraterone vs enzalutamide treatment for metastatic prostate cancer is associated with higher rates of hospitalization, a study found. ....

Saint Louis University , United States , Martinw Schoen , Saint Louis University School Of Medicine , Forest Riekhof , Saint Louis University School , Saint Louis , Clinical Genitourinary ,

Survival Improving in De Novo mHSPC Cases

Survival findings are based on real-world data on metastatic prostate cancer, including de novo HSPC, from SEER and the VHA. ....

United States , Saint Louis University , San Francisco , Martinw Schoen , Veterans Health Administration , Saint Louis Veterans Affairs Medical Center , American Society Of Clinical Oncology , American Society , Clinical Oncology , Cancers Symposium , End Results ,